Protagonist Therapeutics (PTGX) Change in Taxes (2024 - 2025)
Protagonist Therapeutics (PTGX) posted Change in Taxes of -$1.9 million for Q2 2025, down 136.12% sequentially from -$800000.0 in Q1 2025, and down 179.44% YoY from $2.4 million in Q2 2024.
Powered by 
Analysis
Protagonist Therapeutics (PTGX) Change in Taxes (2024 - 2025) Analysis & Trends
Protagonist Therapeutics has reported Change in Taxes for 2 years, with the latest figure at -$1.9 million in Q2 2025.
- Quarterly Change in Taxes fell 179.44% year-over-year to -$1.9 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$2.7 million (down 200.0% YoY) and the FY2025 annual result came in at -$2.7 million, down 200.0% from the prior year.
- Change in Taxes retreated to -$1.9 million in Q2 2025 per PTGX's latest filing, from -$800000.0 in the prior quarter.
- Over five years, Change in Taxes peaked at $3.3 million in Q1 2024 and troughed at -$1.9 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Protagonist Therapeutics | 9.61 Bn | 9.61 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -1.89 Mn |
| Mar 31, 2025 | -800,000.00 |
| Dec 31, 2024 | 1.64 Mn |
| Sep 30, 2024 | -1.60 Mn |
| Jun 30, 2024 | -676,000.00 |
| Mar 31, 2024 | 3.33 Mn |